Tomoda Fumihiro

トモダフミヒロ | Tomoda Fumihiro

Affiliation and department：

Research field (1)： Nephrology

Research keywords (10)： sympathetic nervous system , ideal dialysis , dialyzer , platelet function , blood viscosity , Nerve growth factor , Stress response , Renal disease , Dialysis , Hypertension

Research theme for competitive and other funds (1)：

2000 - 2001 Effect of nerve growth factor on sympathetic neuronal function in heart failure after myocardial infarction

Papers (45)：

Fumihiro Tomoda, Tsutomu Koike, Atsumi Nitta, Hiroko Kurosaki, Hiroko Sugimori, Maiko Oh-hara, Koichiro Kinugawa. Urinary levels of cortisol but not catecholamines are associated with those of 8-hydroxy-2’-deoxyguanosine in uncomplicated primary hypertension. Journal of Hypertension. 2023. 41. 10. 1571-1577
Tsutomu Koike, Teruhiko Imamura, Fumihiro Tomoda, Maiko Ohara, Hayato Fujioka, Kota Kakeshita, Hidenori Yamazaki, Koichiro Kinugawa. Factors Associating with Non-Dipping Pattern of Nocturnal Blood Pressure in Patients with Essential Hypertension. Journal of Clinical Medicine. 2023. 12. 2. 570-570
Hayato Fujioka, Tsutomu Koike, Teruhiko Imamura, Fumihiro Tomoda, Kota Kakeshita, Hidenori Yamazaki, Koichiro Kinugawa. Impact of Geriatric Nutritional Risk Index and Modified Creatinine Index Combination on Mortality in Hemodialysis Patients. Nutrients. 2022. 14. 4. 801-801
Fumihiro Tomoda, Atsumi Nitta, Hiroko Sugimori, Tsutomu Koike, Koichiro Kinugawa. Plasma and Urinary Levels of Nerve Growth Factor Are Elevated in Primary Hypertension. International journal of hypertension. 2022. 2022. 3003269-3003269
Tomoko Mizushige, Hiroyuki Kobori, Hirofumi Hitomi, Yoko Nishijima, Fumihiro Tomoda, Satoshi Morimoto, Masakazu Kohno, Akira Nishiyama. Urinary Angiotensinogen Could Be a Prognostic Marker of the Renoprotection of Olmesartan in Metabolic Syndrome Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2016. 17. 11

ｍore...

MISC (36)：

Hirofumi Hitomi, Hiroyuki Kobori, Fumihiro Tomoda, Satoshi Morimoto, Toshiki Fukui, Koichi Hasegawa, Tsukasa Nakamura, Daisuke Nakano, Masakazu Kohno, Akira Nishiyama. Urinary angiotensinogen as a predictive marker of renoprotective effect of olmesartan in patients with metabolic syndrome. JOURNAL OF PHARMACOLOGICAL SCIENCES. 2013. 121. 111P-111P
Taizo Nakagawa, Taizo Nakagawa, Kumi Ichikawa, Mayumi Miyamoto, Daisuke Takabayashi, Hidenori Yamazaki, Kouta Kakeshita, Tsutomu Koike, Satoshi Kagitani, Fumihiro Tomoda, et al. PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA SIGNAL COULD CONTRIBUTE TO VULNERABILITY AND REPAIRABILITY OF GLOMERULAR CAPILLARY STRUCTURE. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2012. 27. 435-435
T. Koike, F. Tomoda, H. Yamazaki, H. Kinuno, H. Kurosaki, H. Sugimori, S. Kagitani, H. Inoue. Glomerular hyperfiltration as a marker of cardiovascular risk in normoalbuminuric essential hypertensives. JOURNAL OF HYPERTENSION. 2008. 26. S443-S443
M. Ohara, F. Tomoda, T. Koike, H. Liu, H. Kurosaki, H. Yamazaki, H. Sugimori, H. Kinuno, S. Kagitani, H. Inoue. Factors associated with microalbuminuria differ between obese and non-obese patients in essential hypertension. JOURNAL OF HYPERTENSION. 2008. 26. S224-S224
H. Liu, F. Tomoda, T. Koike, H. Kurosaki, H. Yamazaki, M. Ohara, H. Inoue. Elevated platelet derived growth factor and its clinical implications in essential hypertensives with microalbuminuria. JOURNAL OF HYPERTENSION. 2008. 26. S4-S5

ｍore...

Books (8)：

日本臨床増刊最新臨床脳卒中学(上)
日本臨牀社 2014
わかりやすい内科学(第4版)
文光堂出版 2014
病気のシグナル
北日本新聞社出版 2012
日本臨床増刊高血圧(第四版)上
日本臨牀社 2009
日本臨床増刊高血圧(第三版)下
日本臨牀社 2006

ｍore...

Lectures and oral presentations (16)：

本態性高血圧症における血漿キサンチンオキシターゼ活性とその関連因子に関する検討
(第43回日本高血圧学会総会 2021)
本態性高血圧症における収縮期血圧の左右差と高血圧臓器障害の関係
(第43回日本高血圧学会総会 2021)
Factors Affecting the Relationship between Protein Intake and Urinary Albumi
(2019)
Increased Blood Viscosity Implies Clustering of multiple metabolic abnormalities in Essential Hypertensionmultiple metabolic abnormalities in Essential Hypertension
(World Heart Congress 2019 2019)
血液透析患者における筋肉量の関連因子としてのビタミンD ~体組成分析装置を用いての検討~
(第64回日本透析医学会総会 2019)

ｍore...

Education (1)：

1976 - 1982 Toyama Medical and Pharmaceutical University

Professional career (1)：

医学博士 (富山大学)

Work history (6)：

2017/04 - 現在 Fukui Health Science University Faculty of Health Science Professor
2015/04 - 2017/03 Fukui College of Health Sciences Professor
2009/04 - 2015/03 University of Toyama Hospital
2005/10 - 2015/03 University of Toyama Faculty of medicine, the second department of internal medicine associate professor
2005/04 - 2005/09 Toyama medical and pharmaceutical university Faculty of medicine, the second department of internal medicine associate professor

Show all

Committee career (4)：

- 現在日本生活習慣病学会評議委員
- 現在日本高血圧学会評議委員
2005/04 - 2015/03 富山県身体障害者審査委員会(人工透析部門) 委員
2010/04 - 2012/03 介護保険審査会委員

Awards (3)：

2023 - 科研費基盤研究(C) ストレスの新しいバイオマーカーとしての神経成長因子の確立から保険指導法の考案
2012/11 - 腎と高血圧研究会研究助成
1999/03 - 腎性貧血研究会研究助成

Association Membership(s) (6)：

APANESE SOCIETY OF LIFE STYLE DISEASES , The Japanese Circulation Society , APANESE SOCIETY OF HYPERTENSION , Japanese Society for Dialysis Therapy , JAPANESE SOCIETY OF NEPHROLOGY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page